Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy

Luigi Moretti1, Eddy S Yang, Kwang W Kim

  • 1Department of Radiation Oncology, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, 1301 22nd Avenue South, B-902 The Vanderbilt Clinic, Nashville, TN 37232-5671, United States.

Insights

Non-apoptotic programmed cell death, including autophagy, offers novel anticancer therapy strategies. Targeting autophagy can enhance cancer treatment, especially in apoptosis-resistant cancers.

Area of Science:

  • Oncology
  • Cellular Biology
  • Pharmacology

Background:

  • Cancer cells frequently exhibit resistance to apoptosis-inducing therapies due to mutations.
  • Non-apoptotic programmed cell death pathways are crucial for alternative cancer treatment strategies.
  • Autophagy, a cellular self-digestion process, can act as a cell death mechanism when apoptosis is impaired.

Purpose of the Study:

  • To review pathways linking autophagy and cancer for novel therapeutic targets.
  • To identify pharmaceuticals for enhancing cancer therapy by targeting autophagy.

Main Methods:

  • Review of scientific literature on autophagy and cancer.
  • Analysis of experimental data on radiation-induced autophagy in apoptosis-deficient cells.
  • Identification of potential drug targets within the autophagy pathway.

Main Results:

  • Autophagy can induce cell death, particularly in cancer cells with defective apoptosis.
  • Radiation can effectively induce autophagy-mediated cell death.
  • Autophagy's role in cancer is complex, potentially promoting survival or death.

Conclusions:

  • Targeting autophagy presents a promising strategy for overcoming resistance in anticancer therapy.
  • Pharmaceuticals modulating autophagy could improve treatment outcomes for various cancers.
  • Further research into autophagy-cancer pathways is essential for drug development.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...